Clinical Trials Browser

Phase 1/2 × Advanced Prostate Cancer × enzalutamide × Clear all

NCT07198633 2025-09-30

A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer

Phase 1/2 Not yet recruiting

Advanced Prostate Cancer